The main reason for the improvements in facing leukaemia is "the development of new treatments, combined with good levels of recruitment to UK clinical trials", according to the research's lead author.
Dr Anjali Shah, from the London School of Hygiene & Tropical Medicine and the University of Oxford, added:
These key issues have been effective in curing more people of acute myeloid leukaemia (AML).
But levels of cure of this disease in England remain lower than those observed in other European countries, such as Sweden.
The reasons for these differences are unknown.
More top news
Team Sky's Chris Froome is set to win the 2016 Tour de France with an overall lead of four minutes 11 seconds after stage 20 to Morzine
The attempted kidnap of an RAF serviceman took place near RAF Marham, in Norfolk, on Wednesday.
Footballer Marc Crosas faces an investigation after pictures emerged of him appearing to have speared an endangered baby shark